Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM50003017 (CHEMBL3234202) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 0.120 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Florida Curated by ChEMBL | Assay Description Inhibition of VEGF-A production in human HCT116 cells after 12 hrs by alphaLISA assay | J Med Chem 57: 3011-29 (2014) Article DOI: 10.1021/jm4019965 BindingDB Entry DOI: 10.7270/Q2154JKD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM50002930 (CHEMBL3234200) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Florida Curated by ChEMBL | Assay Description Inhibition of VEGF-A production in human HCT116 cells after 12 hrs by alphaLISA assay | J Med Chem 57: 3011-29 (2014) Article DOI: 10.1021/jm4019965 BindingDB Entry DOI: 10.7270/Q2154JKD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM50002918 (Apratoxin S4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Florida Curated by ChEMBL | Assay Description Inhibition of VEGF-A production in human HCT116 cells after 12 hrs by alphaLISA assay | J Med Chem 57: 3011-29 (2014) Article DOI: 10.1021/jm4019965 BindingDB Entry DOI: 10.7270/Q2154JKD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM50002932 (CHEMBL3234201) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 0.470 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Florida Curated by ChEMBL | Assay Description Inhibition of VEGF-A production in human HCT116 cells after 12 hrs by alphaLISA assay | J Med Chem 57: 3011-29 (2014) Article DOI: 10.1021/jm4019965 BindingDB Entry DOI: 10.7270/Q2154JKD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282581 (4-Bromo-5-(3-chloro-5-fluorophenoxy)-2,2-difluoro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282572 ((R)-3-((4-(difluoromethyl)-2,2-difluoro-3-hydroxy-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282632 (5-(3-Chloro-5-fluorophenoxy)-4-(difluoromethyl)- 2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282761 (5-(3-cyano-5-fluoro-phenoxy)-2,2-difluoro-3- hydro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282656 (4-(Difluoromethyl)-5-(3,5-difluorophenoxy)-2,2- di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282686 (US9884843, Compound 30) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282682 (3-((3-Amino-4-(difluoromethyl)-2,2-difluoro-1,1- d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282702 ((R)-3-((4-(Difluoromethyl)-2,2-difluoro-3-hydroxy-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282689 (US9884843, Compound 33) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282634 (3-Amino-4-(difluoromethyl)-5-(3,5- difluorophenoxy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282632 (5-(3-Chloro-5-fluorophenoxy)-4-(difluoromethyl)- 2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282572 ((R)-3-((4-(difluoromethyl)-2,2-difluoro-3-hydroxy-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282584 (4-Chloro-5-(3-chloro-5-fluorophenoxy)-2,2-difluoro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282713 ((R)-4-Bromo-5-(3-chloro-5-fluoro-phenoxy)-2,2- dif...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282598 (5-(3-Chloro-5-fluorophenoxy)-2,2-difluoro-3- hydro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM25115 (3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-({[4-(py...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE MMDB PC cid PC sid PDB UniChem Patents | US Patent | n/a | n/a | 5.27 | n/a | n/a | n/a | n/a | n/a | n/a |
PanOptica, Inc. US Patent | Assay Description Inhibition of VEGF-stimulated VEGFR-2 autophosphorylation in intact cells. | US Patent US9446026 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282564 ((R)-3-((4-bromo-2,2-difluoro-3-hydroxy-1,1-dioxido...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282768 ((3R)-5-(3-cyano-5-fluoro-phenoxy)-2,2- difluoro-3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282750 (US9884843, Compound 94) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282741 ((R)-3-((4-chloro-2,2-difluoro-3-hydroxy-1,1-dioxid...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282685 (3-((4-(Difluoromethyl)-2,2-difluoro-3-hydroxy-1,1-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282597 (US9884843, Compound 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282740 ((R)-3-((4-bromo-2,2-difluoro-3-hydroxy-1,1-dioxido...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282707 (US9884843, Compound 51) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282746 ((R)-4-(Difluoromethyl)-5-(3,4-difluorophenoxy)-2,2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282708 (4-(Difluoromethyl)-5-(3,5-difluorophenoxy)-2,2- di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282711 ((R)-3-Amino-4-(difluoromethyl)-5-(3,5- difluorophe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282685 (3-((4-(Difluoromethyl)-2,2-difluoro-3-hydroxy-1,1-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282745 ((R)-3-((4-(difluoromethyl)-2,2-difluoro-3-hydroxy-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282756 (5-(3,5-Difluorophenoxy)-2,2-difluoro-3- hydroxy-3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282583 (US9884843, Compound 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282753 (US9884843, Compound 97) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 46 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282570 ((3R)-5-(3-chloro-5-fluoro-phenoxy)-3-hydroxy-1,1- ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 47 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282736 (US9884843, Compound 80) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 57 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282719 (3-((4-Ethynyl-2,2-difluoro-3-hydroxy-1,1-dioxido- ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282708 (4-(Difluoromethyl)-5-(3,5-difluorophenoxy)-2,2- di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282715 (US9884843, Compound 59) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282578 (US9884843, Compound 7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 61 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282772 ((3R)-4-bromo-5-(3-bromo-5-fluoro-phenoxy)- 2,2-dif...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 63 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282737 (US9884843, Compound 81) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 67 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282697 ((R)-3-((3-Amino-4-(difluoromethyl)-2,2-difluoro-1,...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 69 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282747 (US9884843, Compound 91) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 72 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282677 (US9884843, Compound 24) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 77 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282754 (4-Bromo-5-(3,5-difluorophenoxy)-2,2- difluoro-3-hy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282698 (3-((2,2-Difluoro-4-(fluoromethyl)-3-hydroxy-1,1- d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 86 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM282599 (US9884843, Compound 15) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | 7.5 | n/a |
PELOTON THERAPEUTICS, INC. US Patent | Assay Description The total assay volume was about 100 μL in the following configuration: 2-μL compound in DMSO, 88 μL buffer with protein and probe and... | US Patent US9884843 (2018) BindingDB Entry DOI: 10.7270/Q2HQ41Z0 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 546 total ) | Next | Last >> |